DigiNepal

A kill switch for epilepsy? China cuts seizures by 92.6% in first human chemogenetic trial

A kill switch for epilepsy? China cuts seizures by 92.6% in first human chemogenetic trial

A kill switch for epilepsy? China cuts seizures by 92.6% in first human chemogenetic trial

For people living with refractory epilepsy, the brain is like a city that can suffer a blackout any time lightning strikes. Without warning, an abnormal neural discharge can sweep through the intracranial circuits, leaving behind convulsions, loss of consciousness and years of lingering panic. Around one-third of epilepsy patients worldwide are completely unresponsive to existing medications,…

www.scmp.com/news/china/science/article/3373500/kill-switch-epilepsy-china-cuts-seizures-926-first-human-chemogenetic-trial

Open in DigiNepal →